139 related articles for article (PubMed ID: 6755558)
21. Dihydrofolate reductase as a therapeutic target for infectious diseases: opportunities and challenges.
Sharma M; Chauhan PM
Future Med Chem; 2012 Jun; 4(10):1335-65. PubMed ID: 22800373
[TBL] [Abstract][Full Text] [Related]
22. Synthesis of quinazoline analogs of isofolic acid.
Hynes JB; Garrett CM
J Med Chem; 1975 Jun; 18(6):632-4. PubMed ID: 1151982
[TBL] [Abstract][Full Text] [Related]
23. Novel quinazoline derivatives. I. Synthesis and preliminary pharmacological evaluation of an anti-inflammatory agent, SL-573.
Komatsu T; Awata H; Sakai Y; Inukai T; Yamamoto M; Inaba S; Yamamoto H
Arzneimittelforschung; 1972 Nov; 22(11):1958-62. PubMed ID: 4679072
[No Abstract] [Full Text] [Related]
24. Synthesis of some new quinazolin-4-one derivatives and evaluation of their antimicrobial and antiinflammatory effects.
Fathalla OA; Kassem EM; Ibrahem NM; Kamel MM
Acta Pol Pharm; 2008; 65(1):11-20. PubMed ID: 18536168
[TBL] [Abstract][Full Text] [Related]
25. Novel quinazoline derivatives. II. A new anti-inflammatory agent, SL-512.
Yamamoto H; Saito C; Inaba S; Awata H; Yamamoto M
Arzneimittelforschung; 1973 Sep; 23(9):1266-71. PubMed ID: 4801218
[No Abstract] [Full Text] [Related]
26. Pyrimidine derivatives. V. Structure-activity studies of antihypertensive quinazoline derivatives using the adaptive least-squares method.
Sekiya T; Imada S; Hata S; Yamada S
Chem Pharm Bull (Tokyo); 1983 Aug; 31(8):2779-85. PubMed ID: 6652822
[No Abstract] [Full Text] [Related]
27. 5-substituted quinazoline antifolates.
Jones TR
Eur J Cancer (1965); 1980 May; 16(5):707-11. PubMed ID: 7389796
[No Abstract] [Full Text] [Related]
28. Potential biologically active agents, XXVII: Synthesis of some 4-substituted phenylmercaptoacetic acids.
Varma RS; Bahadur S; Agnihotri AK
Arch Pharm (Weinheim); 1981 Feb; 314(2):97-103. PubMed ID: 7224829
[No Abstract] [Full Text] [Related]
29. Dihydrofolate reductase inhibitors as potential drugs.
McCormack JJ
Med Res Rev; 1981; 1(3):303-31. PubMed ID: 7050566
[No Abstract] [Full Text] [Related]
30. Synthesis and evaluation of 6-arylactamido-2,4-diaminoquinazolines and related compounds as folic acid antagonists.
Hynes JB; Ashton WT
J Med Chem; 1975 Mar; 18(3):263-5. PubMed ID: 1094114
[TBL] [Abstract][Full Text] [Related]
31. Quinazoline antifolates: biologic activities.
Hutchison DJ
Cancer Chemother Rep; 1968 Dec; 52(7):697-705. PubMed ID: 5754669
[No Abstract] [Full Text] [Related]
32. Recent advances in antimalarial compounds and their patents.
Mital A
Curr Med Chem; 2007; 14(7):759-73. PubMed ID: 17346161
[TBL] [Abstract][Full Text] [Related]
33. Synthesis of piperidine derivatives with a quinazoline ring system as potential antihypertensive agents.
Takai H; Obase H; Teranishi M; Karasawa A; Kubo K; Shuto K; Kasuya Y; Shigenobu K
Chem Pharm Bull (Tokyo); 1986 May; 34(5):1907-16. PubMed ID: 3742649
[No Abstract] [Full Text] [Related]
34. Synthesis, antimicrobial evaluation, and docking studies of novel 4-substituted quinazoline derivatives as DNA-gyrase inhibitors.
Boyapati S; Kulandaivelu U; Sangu S; Vanga MR
Arch Pharm (Weinheim); 2010 Oct; 343(10):570-6. PubMed ID: 20941729
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of thymidylate synthetase by the new quinazoline antifolate, CB 3717; enzyme purification and kinetics.
Jackman AL; Calvert AH; Hart LI; Harrap KR
Adv Exp Med Biol; 1984; 165 Pt B():375-8. PubMed ID: 6720434
[No Abstract] [Full Text] [Related]
36. [Synthesis and antihypertensive activity of various 2,3-dihydro-5H-thiazolo-[2,3-b]quinazoline derivatives].
Liu KC; Chern JW; Yen MH; Lin YO
Arch Pharm (Weinheim); 1983 Jun; 316(6):569-71. PubMed ID: 6882160
[No Abstract] [Full Text] [Related]
37. Quinazoline antifolates with dual biochemical loci of action. Biochemical and biological studies directed towards overcoming methotrexate resistance.
Calvert AH; Jones TR; Dady PJ; Grzelakowska-Sztabert B; Paine RM; Taylor GA; Harrap KR
Eur J Cancer (1965); 1980 May; 16(5):713-22. PubMed ID: 7389797
[No Abstract] [Full Text] [Related]
38. Quinazolines as inhibitors of dihydrofolate reductase. 3. Analogs of pteroic and isopteroic acids.
Hynes JB; Buck JM; D'Souza L; Freisheim JH
J Med Chem; 1975 Dec; 18(12):1191-4. PubMed ID: 811798
[TBL] [Abstract][Full Text] [Related]
39. Quinazoline derivatives as anticancer drugs: a patent review (2011 - present).
Ravez S; Castillo-Aguilera O; Depreux P; Goossens L
Expert Opin Ther Pat; 2015 Jul; 25(7):789-804. PubMed ID: 25910402
[TBL] [Abstract][Full Text] [Related]
40. Discovery of 2-aryloxy-4-amino-quinazoline derivatives as novel protease-activated receptor 2 (PAR2) antagonists.
Cho NC; Cha JH; Kim H; Kwak J; Kim D; Seo SH; Shin JS; Kim T; Park KD; Lee J; No KT; Kim YK; Lee KT; Pae AN
Bioorg Med Chem; 2015 Dec; 23(24):7717-27. PubMed ID: 26631441
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
